|
 Actinogen Limited – Float/IPO expected to close 27 September 2007
Actinogen Limited has developed a series of rapid and specifically directed screening tests directed at searching for antibiotics and anti-fungal agents. These screening tests focus on identifying isolates, which may lead to the development of products capable of commercial applications in medical, agricultural and veterinary fields.
The Company has isolated 2 micro-organisms (isolates) which produce antibiotic activity against “Superbug” Methicillin Resistant Staphylococcus Aureus (MRSA) and Vancomycin Resistant Enterococci (VRE). The potential of these bioactive compounds is enormous.
The Company has established an arrangement with the PathWest laboratories at the QE II Medical Centre at Sir Charles Gardiner Hospital in Perth to utilise laboratories and equipment for carrying out its research into the detection and isolation of the desired actinomycetes and their bioactive compounds.
In addition to the specific activities described above there are numerous potential commercial applications for the bioactive compounds that may be identified by the Company through selective screening techniques. Those applications include other antibiotics, as well as anti– fungal, anti-viral and anti-cancer agents.
It is anticipated that the Company’s screening techniques may be extended to identifying micro-organisms that have application for bio-remedial control of environmental and mining pollutants. Examples include micro-organisms that may digest various sources of cellulose, domestic wastes, toxic chemicals in polluted ground or water, plastics and the treatment of salt affected soils.
Click here for more information and to request a Prospectus.
DWS Global Equity Agribusiness Fund
The DWS Global Equity Agribusiness Fund - the first of its kind in Australia - offers investors an opportunity to participate in the business of feeding the world.
The DWS Global Equity Agribusiness Fund will provide investors with exposure to an actively managed portfolio of Global Agribusiness companies. The fund seeks investments in all parts of the food production-to-consumption value chain via stakes in listed companies worldwide including those involved in:
- crop protection
- acquaculture
- biofels
|
- land and plantations
- seeds and fertilisers
- water and irrigation
|
- climate services
- equipment manufacturing for planting and harvesting
- the marketing and sales of agricultural and food products
|
Click here to view the innovative product trailer.
Using Macquarie Margin lending, you can invest a larger amount, with less money out of your own pocket. The DWS Global Equity Agribusiness Fund is approved to 70% LVR and the current Variable Rate is 9.15%p.a. This means that by using $9,000 of your own money, you could invest up to $30,000 in the fund.
Click here for more information and to request a Prospectus.
|
Newsletter #813 - 30th August 2007
Home
As with all managed fund investments via InvestSMART, you pay NO entry fees, plus you also receive a cash payment from InvestSMART for any trailing commissions we receive from 
